<?xml version='1.0' encoding='utf-8'?>
<document id="21507867"><sentence text="Clinically significant drug-drug interaction between tacrolimus and phenobarbital: the price we pay."><entity charOffset="53-63" id="DDI-PubMed.21507867.s1.e0" text="tacrolimus" /><entity charOffset="68-81" id="DDI-PubMed.21507867.s1.e1" text="phenobarbital" /><pair ddi="false" e1="DDI-PubMed.21507867.s1.e0" e2="DDI-PubMed.21507867.s1.e0" /><pair ddi="false" e1="DDI-PubMed.21507867.s1.e0" e2="DDI-PubMed.21507867.s1.e1" /></sentence><sentence text="The case of a 57-year-old male who experienced acute renal transplant rejection due to subtherapeutic tacrolimus levels as a result of drug interaction with phenobarbital"><entity charOffset="102-112" id="DDI-PubMed.21507867.s2.e0" text="tacrolimus" /><entity charOffset="157-170" id="DDI-PubMed.21507867.s2.e1" text="phenobarbital" /><pair ddi="false" e1="DDI-PubMed.21507867.s2.e0" e2="DDI-PubMed.21507867.s2.e0" /><pair ddi="false" e1="DDI-PubMed.21507867.s2.e0" e2="DDI-PubMed.21507867.s2.e1" /></sentence><sentence text="" /><sentence text="Drug interactions with tacrolimus due to its metabolism through the CYP 450 3A4 enzymatic pathway have led to several reports of altered tacrolimus levels, which can lead to acute rejection in renal transplant recipients"><entity charOffset="23-33" id="DDI-PubMed.21507867.s4.e0" text="tacrolimus" /><entity charOffset="137-147" id="DDI-PubMed.21507867.s4.e1" text="tacrolimus" /><pair ddi="false" e1="DDI-PubMed.21507867.s4.e0" e2="DDI-PubMed.21507867.s4.e0" /><pair ddi="false" e1="DDI-PubMed.21507867.s4.e0" e2="DDI-PubMed.21507867.s4.e1" /></sentence><sentence text=" We describe the case of a 57-year-old male initiated on immunosuppressive therapy with tacrolimus in addition to his anticonvulsant medications"><entity charOffset="88-98" id="DDI-PubMed.21507867.s5.e0" text="tacrolimus" /></sentence><sentence text="" /><sentence text="Upon tacrolimus dose increases, discontinuation of carbamazepine, and minimization of phenobarbital dose, effective tacrolimus trough levels were achieved in our patient"><entity charOffset="5-15" id="DDI-PubMed.21507867.s7.e0" text="tacrolimus" /><entity charOffset="51-64" id="DDI-PubMed.21507867.s7.e1" text="carbamazepine" /><entity charOffset="86-99" id="DDI-PubMed.21507867.s7.e2" text="phenobarbital" /><entity charOffset="116-126" id="DDI-PubMed.21507867.s7.e3" text="tacrolimus" /><pair ddi="false" e1="DDI-PubMed.21507867.s7.e0" e2="DDI-PubMed.21507867.s7.e0" /><pair ddi="false" e1="DDI-PubMed.21507867.s7.e0" e2="DDI-PubMed.21507867.s7.e1" /><pair ddi="false" e1="DDI-PubMed.21507867.s7.e0" e2="DDI-PubMed.21507867.s7.e2" /><pair ddi="false" e1="DDI-PubMed.21507867.s7.e0" e2="DDI-PubMed.21507867.s7.e3" /><pair ddi="false" e1="DDI-PubMed.21507867.s7.e1" e2="DDI-PubMed.21507867.s7.e1" /><pair ddi="false" e1="DDI-PubMed.21507867.s7.e1" e2="DDI-PubMed.21507867.s7.e2" /><pair ddi="false" e1="DDI-PubMed.21507867.s7.e1" e2="DDI-PubMed.21507867.s7.e3" /><pair ddi="false" e1="DDI-PubMed.21507867.s7.e2" e2="DDI-PubMed.21507867.s7.e2" /><pair ddi="false" e1="DDI-PubMed.21507867.s7.e2" e2="DDI-PubMed.21507867.s7.e3" /></sentence><sentence text=" Identification and elimination of such drug-drug interactions is necessary to assure adequate immunosuppression in renal transplant recipients" /><sentence text="" /></document>